Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen

drugsSeptember 20, 2019

Tag: Zantac , Carcinogen , ranitidine , NDMA

PharmaSources Customer Service